--- title: "Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma | BLRX Stock News" type: "News" locale: "en" url: "https://longbridge.com/en/news/281985478.md" description: "Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma | BLRX Stock News" datetime: "2026-04-07T22:30:58.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281985478.md) - [en](https://longbridge.com/en/news/281985478.md) - [zh-HK](https://longbridge.com/zh-HK/news/281985478.md) --- # Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma | BLRX Stock News Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma | BLRX Stock News ### Related Stocks - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [LCTX.US](https://longbridge.com/en/quote/LCTX.US.md) - [BLRX.US](https://longbridge.com/en/quote/BLRX.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [LABD.US](https://longbridge.com/en/quote/LABD.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) ## Related News & Research - [US FDA authorizes early access to Revolution's pancreatic cancer pill](https://longbridge.com/en/news/284922598.md) - [Illumina Q1 revenue beats on demand for NovaSeq X](https://longbridge.com/en/news/284828330.md) - [AbbVie beats Q1 revenue, profit estimates on Skyrizi, Rinvoq demand; lifts profit outlook](https://longbridge.com/en/news/284564851.md) - [Biopharma firm Incyte's Q1 revenue, adjusted profit beat estimates](https://longbridge.com/en/news/284370688.md) - [Erasca To Discuss Early Phase 1 Data For Pan-RAS Molecular Glue ERAS-0015](https://longbridge.com/en/news/284239561.md)